Absorption tablets, white or almost white, flat cylindrical, with a smooth shiny surface, with beveled edges, with a minty odor, slight marbling is allowed.
packaging 8 pcs – blister packagings (5) – packs of cardboard.
Immunostimulating preparation of bacterial origin for topical use in otorhinolaryngology, dentistry. It is a multivalent antigenic complex, a mixture of bacterial lysates, the composition of which corresponds to pathogens that most often cause inflammatory processes in the oral cavity and pharynx.
Imudon activates phagocytosis, increases the number of immunocompetent cells, increases the production of lysozyme and interferon, immunoglobulin A in saliva.
Treatment and / or prevention of inflammatory and infectious diseases of the oral cavity and pharynx:
preoperative preparation and the postoperative period after tonsillectomy
superficial and deep periodontal disease, periodontitis, stomatitis (including aphthous), glossitis
erythematous ulcer disease and tooth ulcerative disease
root ulceration caused by dentures.
children under 3 years of age
increased individual sensitivity to the drug or its components.
Use during pregnancy and lactation
Information on the use of Imudon during pregnancy is insufficient. Relevant data from animal experiments and epidemiological studies are not available. It is not recommended to take Imudon during pregnancy and during lactation (breastfeeding).
a mixture of bacterial lysates (ImudonÂ®) 2.7 mg,
incl. , Enterococcus faecalis, Klebsiella pneumoniae ss pneumoniae, Fusobacterium nucleatum ss fusiforme, Corynebacterium pseudodiphtheriticum, Candida albicans 0.1575 mg
excipients: glycine – 2 mg, sodium deoxycholate – 0.53 mg, max.
Excipients: glycine – 47.3 mg, lactose monohydrate – 350 mg, mannitol – 100 mg, sodium saccharinate – 1.12 mg, povidone – 10 mg, sodium bicarbonate – 30 mg, anhydrous citric acid – 23 mg, mint flavoring – 8 mg, magnesium stearate – 4.88 mg.
Dosage and administration of
Adults and adolescents over 14 years of age with acute inflammatory diseases of the oral cavity and pharynx and exacerbation of chronic diseases are prescribed at a dose of 8 tablets / day. The tablets are resorbed (without chewing) in the oral cavity with an interval of 1-2 hours. The average duration of the course of treatment is 10 days.
To prevent exacerbation of chronic inflammatory diseases of the oral cavity and pharynx, the drug is prescribed at a dose of 6 tablets / day. The tablets are resorbed (without chewing) in the oral cavity with an interval of 2 hours. The duration of the course of treatment is 20 days.
Recommended prophylactic courses 3-4 times a year.
For children aged 3 to 14 years, in the treatment of acute and exacerbation of chronic inflammatory diseases of the oral cavity and pharynx, the drug is prescribed at a dose of 6 tablets / day. The tablets are resorbed (without chewing) in the oral cavity with an interval of 1-2 hours. The duration of the course of treatment for acute diseases is 10 days, for the prevention of exacerbation of chronic diseases – 20 days.
The course of prophylactic use is recommended to be repeated 3-4 times a year.
Allergic reactions: rarely – skin rash, urticaria, angioedema.
From the digestive system: rarely – nausea, vomiting, abdominal pain.
From the respiratory system: rarely – exacerbation of bronchial asthma, cough.
Dermatological reactions: very rarely – erythema nodosum.
From the blood coagulation system: very rarely – hemorrhagic vasculitis, trobocytopenia.
Other: rarely – fever.
No drug interaction was noted. Imudone can be used at the same time as other medicines.
There have been no cases of overdose with Imudon.
The drug should be stored out of the reach of children at a temperature not exceeding 25 ° C. Store and transport the drug in accordance with SP22.214.171.1248-03 at a temperature of no higher than 25 ° C.